European Registry for Myeloproliferative Neoplasms (MPNs)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1010 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-10-08

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Fondazione per la Ricerca Ospedale di Bergamo (FROM) decided to propose and promote the completion of ERNEST registry: the aim of the project is to obtain up-to-date estimates of clinical outcome of these patients in primary and secondary Myelofibrosis that have been included in the 'original' ERNEST study. The last was conducted between 2012 and beginning of 2015 including 1292 patients with Myelofibrosis, but it was interrupted in 2015 because of bankruptcy of the previous sponsor.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors

NCT03141021

Malignant Peripheral Nerve Sheath Tumors

RECRUITING

Observing People With Desmoid-Type Fibromatosis

NCT04281381

Desmoid Fibromatosis

RECRUITING

Functional and Clinical Long-Term Outcome of Ewing Sarcoma Treatment

NCT00824083

Sarcoma, Ewing's

COMPLETED

Multisession Radiosurgery in Residual/Recurrent Grade II Meningiomas.

NCT05081908

Meningioma Atypical

UNKNOWN NA

Treatment of Desmoid Fibromatosis With Arterial Embolization

NCT06945887

Desmoid Fibromatosis

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Follow-up of patients already been registered in the ERNEST registry resulting alive and/or in active surveillance at November 2014 (Blood 2014 124:1849) will be updated retrospectively until December 2020. Data collection will be centralized at Fondazione per la Ricerca Ospedale di Bergamo (FROM), and performed by a web-based and Electronic Data Capture (EDC) system through ad hoc electronic case report forms (e-CRFs). The e-CRFs system will be pre-filled with pre-existing data collected from cases already entered in the registry. Information on therapies received and outcome events occurred (in term of death, evolution to acute leukemia, secondary cancer and cardiovascular complications) until December 2020 will be recorded by authorized participating investigators.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myelofibrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* previous registration in the ERNEST registry (2012 - 2014)
* diagnosis of MF performed between January 2001 and 2012 December
* Signed informed consent to continue participation in the registry